-->

UG Healthcare - Maybank Kim Eng 2016-01-26: Business Remains Solid

UG Healthcare - Maybank Kim Eng 2016-01-26: Business Remains Solid UG HEALTHCARE CORPORATION LTD 41A.SI 

UG Healthcare (UGHC SP) - Business Remains Solid 


Price down 35% in 2 days, but business remains solid 

  • UG Healthcare’s stock price has fallen 35% in the past 2 days on massive volume. 
  • In response to that, we hosted a conference call with management, Mr Lee Jun Yih, Executive Director and our institutional clients. 
  • Management assured that the company remains in good shape and addressed concerns on the operations. 

Production on target, stable pricing and margin 

  • On the production front, things are moving according to plan. 
  • UG started its phase 2 expansion production in Oct 2015 and all the new lines are operational, at optimum utilisation rate of 80-85%. Capacity will reach 1.9b gloves in FY6/16, up from 1.5b in FY6/15. 
  • Management also plans to share more details on its future plan, following its 1H16 results next week. 
  • Further, there is no significant pressure on pricing and margins. 
  • Raw material costs are stable and currency movements are positive for UG. 
  • On fixed costs, management does not expect a significant increase in marketing and administrative costs, with only a small SGD0.2-0.3m increase for recurring listing expense. 
  • UG was only listed in 1HCY15. 

Results preview: potential upside surprise 

  • 1H6/16 results will be released on 3 Feb, next Wednesday after market. 
  • 1H growth should be lower than the full year, at 5-10%, as there was no recurring listing expenses in 1H6/15 and the new capacity only contributed for 2 months. 
  • 2H6/16 should catch up with YoY growth of 80- 90%. 
  • Inferring from the strong USD and low rubber and oil prices, there could be upside surprise to earnings. We have seen other glovemakers benefiting from these. 
  • We expect 38% earnings growth YoY in the full year. 

Attractive valuation & growth; BUY for 46% upside 

  • At SGD0.28, the stock is now lower than when we initiated in Oct 2015, trading at just 13x/10x FY15/16E P/E. 
  • Its peers, which are all larger, have continued to rerate and are trading at 16-35x forward P/E. 
  • Maintain BUY at TP of SGD0.41, based on 14x FY16 P/E, 40% discount to peer average for its smaller size; the discount has increased from 30% after the sector’s positive rerating.



John Cheong CFA Maybank Kim Eng | http://www.maybank-ke.com.sg/ 2016-01-26
Maybank Kim Eng SGX Stock Analyst Report BUY Maintain BUY 0.41 Same 0.41


Advertisement



MOST TALKED ABOUT STOCKS / REITS OF THE WEEK



loading.......